✓ Independent editorial reviews of U.S. telehealth providers · Updated June 1, 2026 · Educational only — not medical advice
Journal · Legitimacy

How to Tell If an Online GLP-1 Provider Is Legit

Practical signs an online GLP-1 telehealth provider is legitimate: state-licensed clinicians, real medical review, disclosed pharmacy, transparent pricing, and accurate compounding language.

Published by Ranika Editorial Group LLCUpdated June 1, 2026
Direct Answer

How can you tell if an online GLP-1 provider is legit?

A legitimate online GLP-1 provider uses clinicians licensed in your state, requires a real medical review before prescribing, discloses its compounding pharmacy, prices transparently, and describes compounded medications accurately — never as “FDA-approved” or “generic Ozempic.” If a provider hides any of these, treat it as a warning sign.

Disclaimer: American Telehealth Review is an editorial resource and does not provide medical advice, diagnosis, or treatment. Compounded medications are not FDA-approved finished drug products and should only be prescribed when clinically appropriate by a licensed healthcare provider. Brand-name medications such as Ozempic, Wegovy, Mounjaro, and Zepbound are FDA-approved under their own applications. Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products.

The signals that matter

  • Licensed clinicians in your state
  • A documented medical review before any prescription
  • A named compounding pharmacy you can verify
  • Clear, all-in monthly pricing
  • Accurate compounding language

Verify before you pay

Run the 8-point checklist and confirm pricing against an independent GLP-1 price index.

Frequently asked questions

Is online GLP-1 telehealth legit?

It can be, when the provider is licensed, reviews eligibility medically, discloses its pharmacy, and prices transparently.

What is the clearest sign of a scam?

Calling compounded medication “FDA-approved” or “generic Ozempic” — both are misleading.

Sources

  • U.S. FDA — Medications containing semaglutide and tirzepatide (fda.gov).
  • Federation of State Medical Boards — Telemedicine policy resources (fsmb.org).
  • U.S. FDA — Compounding and the FDA (fda.gov).

Related resources